Malaysian Health Technology Assessment Section (MaHTAS)
is tasked to provide evidence-based input on health technology and clinical practice.
is tasked to provide evidence-based input on health technology and clinical practice.
Latest fromMaHTAS
Advancing Evidence-Based Healthcare: MaHTAS Welcomes GIN 2026 to Kuala Lumpur!
The Malaysian Health Technology Assessment Section (MaHTAS), Ministry of Health Malaysia, is honored to serve on the organizing committee for the Guidelines International Network (GIN) 2026 Annual Conference.
Themed "Guidelines for All: Bridging Tradition, Technology and High-Value Care," this prestigious event will bring together global experts at the Kuala Lumpur Convention Centre (KLCC) to shape the future of clinical and public health guidelines.
As we bridge the gap between innovation and implementation, we invite our professional network to contribute their expertise and join the conversation.
📅 Save the Date: 15th – 18th September 2026 📍 Venue: KLCC, Kuala Lumpur, Malaysia
Important Deadlines: Abstract Submissions: Open now until 16 February 2026 (Extended until 27 February 2026)
Early Bird Registration: Closes 1 June 2026
Don’t miss the chance to showcase your research and engage with the global evidence-based community.
đź”— Learn more and submit your abstract here: https://g-i-n.net/gin-conference-2026/welcome
Health Benefit Package Seminar: Presentation of Research Findings
Date: 21 November 2025
MaHTAS hosted a Townhall Session at PICC to present research findings on developing a national framework for an Explicit Health Benefit Package. The session, officiated by the Director-General of Health, brought together 127 participants from MOH, government agencies, NGOs, and patient groups to discuss equitable, evidence-based priority-setting for Malaysia’s healthcare system. Strong stakeholder support reaffirmed the commitment to advancing a transparent, high-value health benefit package for all Malaysians.
HTA-CPG Council Meeting 2/2025
Date: 20 November 2025
Chaired by the Director-General of Health, the HTA-CPG Council Meeting gathered leaders across MOH, hospitals, universities, and advisory committees. The council reviewed and endorsed four CPGs, one HTA report, multiple technology reviews, and five Horizon Scanning TechBriefs covering a wide range of clinical and technological developments. The meeting reinforced Malaysia’s commitment to evidence-based, safe, and cost-effective healthcare, with all endorsed documents to be published on the MaHTAS and MOH websites.
ASEAN Regional Cooperation on Harmonisation of HTA Reporting Formats
Date: 12–13 November 2025
MaHTAS participated as co-lead in the Second ASEAN Workshop on harmonising HTA reporting formats in Makati City, Manila. Malaysia’s delegation worked alongside HTA Philippines and other ASEAN Member States to refine reporting templates for pharmaceuticals and medical devices. The workshop strengthened regional collaboration and supported efforts toward more consistent, evidence-informed policymaking across ASEAN.
Centre of Informed Decision Making in Malaysia
"Is it safe? Is it effective? Is it cost-effective"
MaHTAS is responsible in assessing health technologies and advocating evidence-informed decision-making for better health care.
MaHTAS is responsible in assessing health technologies and advocating evidence-informed decision-making for better health care.
MaHTAS conduct horizon scanning, health technology assessment (HTA), develop and implement Clinical Practice Guidelines (CPG).